MA38451A1 - Benzoimidazol-2-ylpyrimidines modulating the histamine h4 receptor - Google Patents

Benzoimidazol-2-ylpyrimidines modulating the histamine h4 receptor

Info

Publication number
MA38451A1
MA38451A1 MA38451A MA38451A MA38451A1 MA 38451 A1 MA38451 A1 MA 38451A1 MA 38451 A MA38451 A MA 38451A MA 38451 A MA38451 A MA 38451A MA 38451 A1 MA38451 A1 MA 38451A1
Authority
MA
Morocco
Prior art keywords
ylpyrimidines
benzoimidazol
receptor
histamine
modulating
Prior art date
Application number
MA38451A
Other languages
French (fr)
Inventor
Magali B Hickey
Stefan Horns
Susanne Lochner
Matteo Conza
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Priority claimed from PCT/US2014/021130 external-priority patent/WO2014138368A1/en
Publication of MA38451A1 publication Critical patent/MA38451A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des benzoimidazol-2-ylpyrimidines, leurs procédés de purification, des compositions pharmaceutiques et des méthodes de traitement d'états pathologiques, de troubles et de maladies médiés par l'activité du récepteur de hThe invention relates to benzoimidazol-2-ylpyrimidines, methods for their purification, pharmaceutical compositions and methods for treating disease states, disorders and diseases mediated by h receptor activity.

MA38451A 2013-03-06 2014-03-06 Benzoimidazol-2-ylpyrimidines modulating the histamine h4 receptor MA38451A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361773706P 2013-03-06 2013-03-06
PCT/US2014/021130 WO2014138368A1 (en) 2013-03-06 2014-03-06 Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor

Publications (1)

Publication Number Publication Date
MA38451A1 true MA38451A1 (en) 2017-07-31

Family

ID=56119066

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38451A MA38451A1 (en) 2013-03-06 2014-03-06 Benzoimidazol-2-ylpyrimidines modulating the histamine h4 receptor

Country Status (2)

Country Link
AR (1) AR095033A1 (en)
MA (1) MA38451A1 (en)

Also Published As

Publication number Publication date
AR095033A1 (en) 2015-09-16

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
ECSP10010226A (en) COMPOUNDS DERIVED FROM AMINA TO TREAT DISEASES AND Ophthalmic Disorders
TR201901886T4 (en) DNA-PK inhibitors.
EA200901032A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
EA201001329A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
EA201100138A1 (en) 4-PHENOXYMETHYL-PIPERIDINES AS MODEL ACTIVITY GPR119
EA201790519A1 (en) THERAPEUTIC CONNECTIONS AS INTEGRATORS OF OREXIN-1 RECEPTOR
EA201591535A1 (en) SUBSTITUTED DERIVATIVES OF 3-PHENYL-PROPYLAMINE FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES AND DISORDERS
EA201001332A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
EA201591648A1 (en) BENZIMIDAZOL-2-IL-Pyrimidine modulators of histamine H4 receptor
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
EA201400969A1 (en) NEW THERAPEUTIC APPROACHES FOR THE TREATMENT OF PARKINSON'S Disease
MA47356A1 (en) Isochromene derivatives useful as inhibitors of phosphoinositide 3-kinases
EA201500112A1 (en) 3-SUBSTITUTED DERIVATIVES ESTRA-1,3,5 (10), 16-TETRAENA, METHODS OF THEIR PRODUCTION, PHARMACEUTICAL MEANS, WHICH CONTAIN THEM, AND THEIR USE FOR RECEPTION OF MEDICINES
EA201001330A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
FR3012725B1 (en) COMPOSITIONS OF BIOLOGICAL CONTROL AGENTS, PROCESS FOR THEIR PREPARATION AND USES THEREOF
EA201200570A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
MA38076A1 (en) Oxazolidin-2-one-pyrimidine derivatives
GB201302343D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods for using the same
CY1116158T1 (en) Substituted 2-oxo- and 2-thiooxy-dihydroquinoline-3-carboxamides as KCNQ2 / 3 modulators
TR201908151T4 (en) Isoindoline derivatives.
BR112013029416A2 (en) substituted indole derivatives for the treatment of immune disorders
MA38451A1 (en) Benzoimidazol-2-ylpyrimidines modulating the histamine h4 receptor
CY1118255T1 (en) Substituted 6-amino-nicotinamides which carry a group containing KCNQ2 / 3 modulators